- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05386251
Effectiveness of a Digital Strategy-based Educational Skills Group for Secondary Students With Organization and Academic Motivation Challenges (STAND-G)
The purpose of this study is to test the effectiveness of a telehealth-delivered skills training versus active control group for middle and high school students with ADHD symptoms. Both programs will be delivered digitally (via Zoom).
Investigators will measure student functioning at baseline, post-group, and three-month follow-up. The primary outcomes are ADHD symptoms, student grade point average, and attendance as reported in the gradebook. Secondary outcomes include parent academic support, autonomy, academic motivation, and organization skills. Participant satisfaction with the group will be measured post-group. Group attendance and homework completion will also be measured.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
120 middle and high school students with elevated ADHD symptoms will be recruited for this study, which will take place over the course of the 2021-2022 academic year. The recruitment strategy will be to distribute information about the study opportunity to educator email lists in South Florida (see appended email template). Educators will be instructed to share information about the study to the parents of students who perceive to experience ADHD symptoms in their schools, regardless of special education status or documentation of a disability.
Students who enroll will be randomly assigned to either receive the STAND-G strategy-based group or a peer-support-based, active control group. Investigators will blind participants and their parents to which group is the active treatment by informing parents and students that participant will be randomly assigned to one of two groups to help improve school difficulties in youth. The two groups will be of equal duration, both will be led by the same instructors; and will differ only in content (teaching strategies vs. facilitating peer support and problem-solving conversations).
Students (and their parents) will complete assessments at baseline, post-group, and three months post-group. School records will be obtained for all time points.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Contact
- Name: Margaret Sibley, Ph.D.
- Phone Number: 206) 884-1424
- Email: margaret.sibley@seattlechildrens.org
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Students will be required to,
- be in the sixth through twelfth grade,
- have elevated ADHD symptoms
- documented impairment according to the SNAP
- documented impairment according to Impairment Rating Scale.
- Students must be 17.5 or younger at the time of enrollment to ensure that they are still under 18 at the expected completion of the study.
Parents of eligible students will also participate.
Exclusion Criteria:
Students may not be,
- in a self-contained special education classroom,
- possess intellectual disability
- be non-English speaking
- be older than 18 years old at time of enrollment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Behavioral Parent Training/Organization Skills Training
Parents will receive 8 weeks of a 90 minute behavioral parent training protocol that focuses on supporting academic and behavioral success in adolescents with ADHD.
Teens will receive a simultaneous 8 weeks of a 90 minute organization skills training group.
Both groups will be delivered via telehealth.
|
See Arm description.
Other Names:
|
Sham Comparator: Peer support
Parents and teens will each participate in 8 weeks of a 90 minute peer support group focused on exchange of shared experience and group problem-solving difficulties.
Both groups will be delivered via telehealth.
|
See Arm description
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ADHD Symptoms
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Parent and Self Ratings on the SNAP Rating Scale
|
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Academic Impairment: Grade Point Average
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Official School Records
|
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Academic Impairment: School Attendance
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Official School Records
|
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Academic Motivation
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Expectancy-Value Questionnaire -Self Version
|
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Academic Motivation
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Change Ruler -Self Version
|
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Executive Functions
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
BRIEF Rating Scale -Parent Version
|
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Organization, Time Management, and Planning
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Adolescent Academic Problems Checklist-Parent and Self Version will be used to measure organization, time management and planning
|
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Parent Academic Involvement
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Parent Academic Management Scale - Parent Version
|
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Academic Impairment Rating Scale
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Impairment Rating Scale - Parent Version
|
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Parent-Teen Conflict
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Conflict Behavior Questionnaire-20 - Parent, Self Version
|
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Goal Setting
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Goal Setting Questionnaire- Parent and Self
|
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Parent Autonomy Support
Time Frame: Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Parent Promotion of Volitional Functioning- Self Report
|
Change from Baseline through 3 months after Post-Treatment, an average of 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment Satisfaction
Time Frame: At Post-treatment, approximately 8 weeks after initial group session
|
Parent and Self Report Satisfaction Survey
|
At Post-treatment, approximately 8 weeks after initial group session
|
Treatment Fidelity
Time Frame: Through Treatment Completion, an average of 8 weeks
|
Blinded Observers will observe to code for fidelity
|
Through Treatment Completion, an average of 8 weeks
|
Treatment Barriers
Time Frame: At Post-treatment, approximately 8 weeks after initial group session
|
Parent an Self Reported Barriers Survey
|
At Post-treatment, approximately 8 weeks after initial group session
|
Treatment Credibility
Time Frame: At Post-treatment, approximately 8 weeks after initial group session
|
Client Credibility Questionnaire-Parent and Self
|
At Post-treatment, approximately 8 weeks after initial group session
|
Video Conferencing Feasibility
Time Frame: At Post-treatment, approximately 8 weeks after initial group session
|
Video-Conferencing Questionnaire-Parent and Self
|
At Post-treatment, approximately 8 weeks after initial group session
|
Treatment Attendance
Time Frame: Through study completion, an average of 8 weeks, at each Session of Treatment
|
Group records
|
Through study completion, an average of 8 weeks, at each Session of Treatment
|
Treatment Homework Completion
Time Frame: Through study completion, an average of 8 weeks, at each Session of Treatment
|
Group records
|
Through study completion, an average of 8 weeks, at each Session of Treatment
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 00003308
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ADHD
-
The Hong Kong Polytechnic UniversityRecruiting
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Recruiting
-
VIZO Specs LtdRecruiting
-
Loewenstein HospitalWingate InstituteRecruiting
-
Florida State UniversityRecruiting
-
Florida International UniversityRecruiting
-
Region Örebro CountyRecruiting
-
Johns Hopkins UniversityWithdrawn
-
Tris Pharma, Inc.Premier Research Group plcCompleted
Clinical Trials on BPT/OST
-
University of OregonLoma Linda UniversityCompletedBehavior Problem | Development DelayUnited States
-
Assistance Publique Hopitaux De MarseilleCompletedBariatric Surgery (Sleeve Gastrectomy )France
-
Stockholm UniversityCompletedPhobia, SpecificSweden
-
Lumos Labs, Inc.Collaborative Neuroscience NetworkCompletedHealthy VolunteersUnited States
-
Oncostellae S.LCompletedUlcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic SevereSpain, Ukraine
-
NYU Langone HealthNational Institute of Mental Health (NIMH)CompletedADHD | Neurodevelopmental Disorders | Attention Deficit Hyperactivity DisorderUnited States
-
Pharmbio Korea Co., Ltd.Not yet recruitingIntestinal Disease | Colonic Disease
-
Lumos Labs, Inc.CompletedHealthy VolunteersUnited States
-
Dartmouth-Hitchcock Medical CenterNational Institute on Drug Abuse (NIDA)Completed
-
New York UniversityCompletedAttention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder | Disruptive BehaviorUnited States